Under construction – not a live service
Sign in
Taking people in United StatesPhase 1/2

Testing a wearable robot to help early stroke recovery in bed

Tests a wearable robot that guides movement exercises in adults with acute stroke.

Plain-language title generated from the registry record
Registry title: Facilitating Neuroplastic Changes of Acute Stroke Survivors

Key facts

Where
Baltimore and Houston, United StatesSee the 3 sites
Phase
Phase 1/2

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 30 and 85 years old?

Source: NCT06404268, who can take part

Where in United States

  • UMROIBaltimore, United StatesTaking people
  • University of Maryland, BaltimoreBaltimore, United StatesTaking people
  • TIRR Memorial HermannHouston, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Maryland, Baltimore
Trial code
NCT06404268
Record updated
23 July 2026
Original description
This project will develop a wearable rehabilitation robot suitable for in-bed acute stage rehabilitation. It involves robot-guided motor relearning, passive and active motor-sensory rehabilitation early in the acute stage post-stroke including patients who are paralyzed with no motor output. The early acute stroke rehabilitation device will be evaluated in this clinical trial.Read full original descriptionShow less

Facilitating Neuroplastic Changes of Acute Stroke Survivors With Severe Hemiplegia

This project will develop a wearable rehabilitation robot suitable for in-bed acute stage rehabilitation. It involves robot-guided motor relearning, passive and active motor-sensory rehabilitation early in the acute stage post-stroke including patients who are paralyzed with no motor output. The early acute stroke rehabilitation device will be evaluated in this clinical trial.

Inclusion: Acute first time unilateral hemispheric stroke (hemorrhagic or ischemic stroke, 24 hours after admission to 1 month post-stroke at the start of the proposed treatment); Hemiplegia or hemiparesis; 0≤Manual Muscle Testing (MMT)<=2; Age 30-85; Ankle impairments including stiff calf muscles and/or inadequate dorsiflexion.

Exclusion: Associated acute medical illness that interferes with ability to training and exercise; No impairment or very mild ankle impairment of ankle; Cognitive impairment or aphasia with inability to follow instructions; Pressure ulcer, recent surgical incision or active skin disease with open wounds present below knee; Medically not stable; Severe cardiovascular problems that interfere with ability to perform moderate movement exercises; Severe pain in legs; Severe ankle contracture greater than 15° plantar flexion (when pushing ankle to dorsiflexion).

ClinicalTrials.gov NCT06404268